Bristol Myers Squibb (BMY)

Cost of Revenue

$14.68B

TTM · Period ending: · USD

BMY logo

BMY Cost of Revenue

Latest reported$14.68B
BMY TTM Cost of Revenue ($0.00 → $14.68B)
High-resolution chart · PNG

BMY cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
14,679,000,000
14,325,000,000
13,937,000,000
14,652,000,000
14,174,000,000
14,069,000,000
13,968,000,000
11,901,000,000
11,450,000,000
11,059,000,000
10,693,000,000
10,541,000,000
10,388,000,000
10,232,000,000
10,137,000,000
9,900,000,000
9,838,000,000
9,570,000,000
9,940,000,000
10,494,000,000
10,705,000,000
10,952,000,000
11,773,000,000
11,295,000,000
10,583,000,000
9,856,000,000
8,018,000,000
7,276,000,000
7,134,000,000
6,787,000,000
6,547,000,000
6,530,000,000
6,461,000,000
6,405,000,000
6,086,000,000
5,796,000,000
5,522,000,000
5,159,000,000
4,946,000,000
4,515,000,000
4,307,000,000
4,114,000,000
3,909,000,000
3,923,000,000
3,833,000,000
3,811,000,000
3,932,000,000
4,239,000,000
4,407,000,000
4,524,000,000
4,619,000,000
4,421,000,000
4,233,000,000
4,370,000,000
4,610,000,000
4,902,000,000
5,322,000,000
5,558,000,000
5,598,000,000
5,645,000,000
5,518,000,000
5,314,000,000
5,277,000,000
4,567,000,000
4,604,000,000
4,552,000,000
4,411,000,000
5,229,000,000
5,546,000,000
5,991,000,000
6,396,000,000
6,529,000,000
6,373,000,000
6,111,000,000
5,881,000,000
5,673,000,000
5,660,000,000
5,820,000,000
5,956,000,000
6,104,000,000
6,122,000,000
6,037,000,000
5,928,000,000
4,228,000,000
4,212,000,000
4,229,000,000
4,219,000,000
6,527,000,000
6,989,000,000
7,341,000,000
7,693,000,000
7,256,000,000
6,981,000,000
6,595,000,000
6,388,000,000
6,236,000,000
5,899,000,000
5,780,000,000
5,561,000,000
5,049,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.